Author: Press Room

Republican South Carolina Rep. Nancy Mace called out House colleagues who have not condemned the sexual violence of Israeli women at the hands of Hamas.”Where are the women’s groups who profess to be fighting for women around the world who’ve been dead silent on this issue? And then look at my colleagues in the House. Where are they?” Mace said on “Fox News Sunday.”Videos and photos on social media, as well as Israeli police accounts, have detailed that Israeli women have faced violent rape crimes after Hamas launched attacks on the nation on Oct. 7. Mace reacted to a series of…

Read More

Cigna and Humana called off a potentially massive merger.The deal between the two companies would have created a $140 billion conglomerate.Cigna still believes a merger with Humana has merit, The Wall Street Journal reported. Loading Something is loading. Thanks for signing up! Access your favorite topics in a personalized feed while you’re on the go. download the app Cigna is giving up on its merger with Humana, which would have created a healthcare giant worth $140 billion, according to reports.The deal between Cigna and Humana would have created a massive conglomerate that would have helped it compete with the nation’s…

Read More

© Reuters. FILE PHOTO: Ukrainian President Volodymyr Zelenskiy is embraced by U.S. President Joe Biden in the Oval Office of the White House in Washington, September 21, 2023. REUTERS/Kevin Lamarque/File Photo WASHINGTON (Reuters) -U.S. President Joe Biden has invited Ukraine President Volodymyr Zelenskiy to a Dec. 12 meeting at the White House to discuss the ongoing war against Russia and the “vital importance” of continued U.S. support of their defense efforts. In a statement on Sunday, the White House said the two will discuss Ukraine’s “urgent needs” facing Ukraine, and comes as the White House looks to strike an agreement…

Read More

2/2 © Reuters. FILE PHOTO: Head of Strategy, Energy Transition of the Office of the UAE Special Envoy for Climate Change, Abdulla Malek addresses the panellists at the opening ceremony for Energy Day during the United Nations Climate Change Conference COP28 in Dubai, Un 2/2 By Ross Kerber, Simon Jessop and Peter Henderson BOSTON/DUBAI/SAN FRANCISCO (Reuters) – A growing list of global companies are setting a price or charging themselves for each metric ton of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules. Their prices are all over the…

Read More

umitarda/iStock Editorial via Getty Images Bosch plans to cut at least 1,500 jobs at two of its factories in Germany by 2025 to keep headcount in line with changing demand and technologies in the automotive industry, the maker of car parts said on Sunday. The plans, first reported by trade publication Automobilwoche, will affect factories in Stuttgart-Feuerbach and Schwieberdingen. More on automotive industry

Read More

The events also drew a wide array of politicians and others, who congregated to demonstrate their support for him — and their distaste for Mr. Biden’s likely opponent. Two of the state’s best-known elected officials, Gov. Gavin Newsom and Representative Nancy Pelosi, attended Friday’s event, and a third, Senator Alex Padilla, was present at the fund-raiser on Saturday.One surprising co-sponsor of Friday’s fund-raiser was Rick Caruso, a billionaire and recent Democratic convert who lost his bid for mayor of Los Angeles last year. (Mr. Biden endorsed his opponent, Karen Bass, who won the election. She also attended on Friday.)Mr. Caruso,…

Read More

Alex Jones’ X account has been restored, five years after Twitter permanently banned him.Elon Musk reinstated the account after polling X users on the matter.Jones is best known for spreading the conspiracy theory that the 2012 Sandy Hook shooting was a hoax. Loading Something is loading. Thanks for signing up! Access your favorite topics in a personalized feed while you’re on the go. download the app Elon Musk has restored the X account of Alex Jones, the Infowars founder who was permanently banned from the platform formerly known as Twitter more than five years ago.Jones, a far-right commentator best known…

Read More

© Reuters. FILE PHOTO: Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly/File Photo (Reuters) -A possible deal between U.S. health insurers Cigna (NYSE:) and Humana (NYSE:) has been abandoned over terms, sources familiar with the deal told Reuters on Sunday. Such a deal likely would have faced scrutiny from the U.S. Justice Department (DOJ), which in 2017 successfully stopped Anthem, now Elevance Health, from buying Cigna for $54 billion, and thwarted Aetna’s plan to purchase rival Humana for $34 billion. Here’s a look at what happened with…

Read More

© Reuters Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with ProPicks, our newest product featuring strategies that have outperformed the S&P 500 by up to 700%. This Cyber Monday, enjoy up to 60% off, plus an extra 10% off a 2-year subscription with the code research23, reserved for the first 500 quick subscribers. To ensure ongoing access to valuable content like this, step up your investment game with InvestingPro. In the biopharmaceutical landscape, Alnylam Pharmaceuticals emerges as a company of interest, with its commitment to…

Read More

jittawit.21 KeyBanc has initiated coverage of the digital biology and tech-enabled drug discovery subsector, citing the biopharma industry’s growing appetite for products that can help speed drugs to market and reduce the exorbitant costs associated with drug development. The investment bank kicked off its coverage by rating Abcellera (NASDAQ:ABCL), Absci (NASDAQ:ABSI) and Schrodinger (NASDAQ:SDGR) as overweight, and Certara (NASDAQ:CERT) as sector weight. The bank also included Codexis (CDXS), Recursion (RXRX) and Simulations Plus (SLP) in the subsector. The companies have faced significant headwinds from a number of macro factors in recent months, including slowdowns in biotech funding and rising interest…

Read More